METHODS FOR TREATING HCV

The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 16 weeks, alternatively no more than 12 weeks, or alternatively no more than 8 weeks. ln one aspect, the treatment comprises admi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEI, YANG, LIU, RAN, PILOT-MATIAS, TAMI, WANG, STANLEY, KRISHNAN, PREETHI, GULATI, ABHISHEK, KOSLOSKI, MATTHEW, PUGATCH, DAVID, NG, IOK CHAN, KORT, JENS, DUMAS, EMILY O, COLLINS, CHRISTINE, VIANI, ROLADO M, RHEE, SUSAN, ZHANG, ZHENZHEN, LIN, CHIH-WEI, HU, YIRAN BONNIE, SHULMAN, NANCY S, TRINH, ROGER, FU, BO, MENSA, FEDERICO
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 16 weeks, alternatively no more than 12 weeks, or alternatively no more than 8 weeks. ln one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 16, 12, or 8 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.